Hermes Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | $56.2M | Buy |
194,945
+2,634
| +1% | +$760K | 0.75% | 43 |
|
|
2018
Q1 | $48.1M | Buy |
192,311
+654
| +0.3% | +$164K | 0.7% | 49 |
|
|
2017
Q4 | $45.7M | Sell |
191,657
-2,439
| -1% | -$582K | 0.66% | 54 |
|
|
2017
Q3 | $43.1M | Sell |
194,096
-6,744
| -3% | -$1.5M | 0.65% | 54 |
|
|
2017
Q2 | $45.5M | Sell |
200,840
-97,533
| -33% | -$22.1M | 0.74% | 45 |
|
|
2017
Q1 | $59.5M | Sell |
298,373
-13,339
| -4% | -$2.66M | 0.96% | 32 |
|
|
2016
Q4 | $56.8M | Buy |
311,712
+43,280
| +16% | +$7.89M | 0.97% | 34 |
|
|
2016
Q3 | $44M | Buy |
268,432
+18,814
| +8% | +$3.08M | 0.75% | 47 |
|
|
2016
Q2 | $35.7M | Buy |
249,618
+65,128
| +35% | +$9.31M | 0.72% | 52 |
|
|
2016
Q1 | $25.7M | Sell |
184,490
-30,596
| -14% | -$4.27M | 0.54% | 76 |
|
|
2015
Q4 | $29.8M | Buy |
215,086
+12,295
| +6% | +$1.7M | 0.67% | 60 |
|
|
2015
Q3 | $27.2M | Sell |
202,791
-1,694
| -0.8% | -$228K | 0.7% | 61 |
|
|
2015
Q2 | $30.8M | Buy |
204,485
+3,944
| +2% | +$594K | 0.69% | 61 |
|
|
2015
Q1 | $27.1M | Buy |
200,541
+24,913
| +14% | +$3.37M | 0.63% | 73 |
|
|
2014
Q4 | $21.2M | Sell |
175,628
-42,753
| -20% | -$5.15M | 0.55% | 82 |
|
|
2014
Q3 | $24.8M | Buy |
218,381
+3,825
| +2% | +$434K | 0.64% | 73 |
|
|
2014
Q2 | $25.7M | Sell |
214,556
-35,858
| -14% | -$4.29M | 0.71% | 63 |
|
|
2014
Q1 | $32.1M | Buy |
+250,414
| New | +$32.1M | 1.01% | 48 |
|